Rush Enterprises, Inc. Reports Fourth Quarter and Year-End 2024 Results, Announces $0.18 per Share Dividend
GlobeNewswire· 2025-02-18 21:05
Annual revenues of $7.8 billion; net income of $304.2 millionAnnual earnings per diluted share of $3.724th quarter revenues of $2.0 billion; net income of $74.8 millionBoard declares cash dividend of $.18 per share of Class A and Class B common stock SAN ANTONIO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Rush Enterprises, Inc. (NASDAQ: RUSHA & RUSHB), which operates the largest network of commercial vehicle dealerships in North America, today announced that for the year ended December 31, 2024, the Company achieved ...
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
GlobeNewswire· 2025-02-18 21:05
Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC-114 in combination with subcutaneous amivantamab for the first-line treatment of NSCLC patients with EGFR exon 20 insertion mutations Expects to report seven data readouts across ORIC-114 and ORIC-944 clinical programs over the next 18 mon ...
Stitch Fix Announces Date for Second Quarter 2025 Financial Results and Conference Call
GlobeNewswire· 2025-02-18 21:05
SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2025 ended February 1, 2025 after market close on Tuesday, March 11, 2025. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of t ...
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
GlobeNewswire· 2025-02-18 21:05
SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, and Scott Blumberg, CFO, will participate in a fireside chat at the upcoming 45th Annual TD Cowen Health Care Conference. The fireside chat will take place on Monday, March 3, 2025, at 6:50 a.m. Pacific Standard Time / 9:50 ...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire· 2025-02-18 21:05
Core Insights - Tactile Systems Technology, Inc. reported strong financial results for Q4 and full year 2024, highlighting a dynamic year with significant product launches and operational improvements [3][4][9]. Financial Performance - Q4 2024 total revenue increased by $7.9 million, or 10%, reaching $85.6 million compared to $77.7 million in Q4 2023, driven by an 11% increase in lymphedema product sales [4][7]. - Gross profit for Q4 2024 rose by $8.4 million, or 15%, to $64.4 million, with a gross margin of 75.2%, up from 72.1% in Q4 2023 [5][7]. - Operating income for Q4 2024 was $12.5 million, compared to $11.8 million in Q4 2023 [6][8]. - Full year 2024 total revenue increased by $18.6 million, or 7%, to $293.0 million, with a gross margin of 74%, up from 71% in 2023 [9][10]. Net Income and Earnings - Q4 2024 net income was $9.7 million, or $0.40 per diluted share, compared to $8.2 million, or $0.35 per diluted share, in Q4 2023 [8][10]. - Full year 2024 net income was $17.0 million, or $0.70 per diluted share, down from $28.5 million, or $1.23 per diluted share, in 2023 [10]. Cash Flow and Balance Sheet - Operating cash flow for 2024 was $40.7 million, compared to $35.9 million in 2023, with cash at year-end 2024 totaling $94.4 million, up from $61.0 million at the end of 2023 [7][11]. - The company ended 2024 with $26.3 million in outstanding borrowings, down from $29.3 million in 2023 [11]. Strategic Outlook - For 2025, the company expects total revenue to be in the range of $316 million to $322 million, representing growth of approximately 8% to 10% year-over-year [12]. - The company plans to continue investing in enhancing the overall patient experience and expanding treatment options [3].
Fidus Investment Corporation Declares First Quarter 2025 Dividend
GlobeNewswire· 2025-02-18 21:05
EVANSTON, Ill., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that its Board of Directors on February 18, 2025 declared a base dividend of $0.43 per share and a supplemental dividend of $0.11 per share for the first quarter of 2025. The Company’s dividends will be payable on March 27, 2025 to stockholders of record as of March 20, 2025. When declaring dividends, the Company’s Board of Directors reviews estimates of taxable income avai ...
Allbirds Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
GlobeNewswire· 2025-02-18 21:05
SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make products in a better way, today announced that its fourth quarter and full year 2024 financial results will be released after market close on Tuesday, March 11, 2025. The company will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the conference call will be available on ...
Devon Energy Reports Fourth-Quarter 2024 Results and Declares and Raises Quarterly Dividend
GlobeNewswire· 2025-02-18 21:05
OKLAHOMA CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for the fourth-quarter 2024. The company also declared its quarterly dividend and provided a 2025 outlook. Devon’s earnings release, supplemental financial tables, guidance and related earnings presentation can be accessed via the Investor Relations section of Devon’s website, www.devonenergy.com. The company’s fourth-quarter conference call will be held at 10:00 a.m. Central time ...
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
GlobeNewswire· 2025-02-18 21:05
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27, 2025, to discuss Clover Health’s fourth quarter and full year 2024 business and financial results. Fourth Quarter and Full Year 2024 Conference Call and Webcast ...
NextNRG, Inc. Announces Closing of Public Offering
GlobeNewswire· 2025-02-18 21:05
NextNRG, Inc. is Trading Under the New Ticker Nasdaq: NXXT after Closing of Share Exchange with Ezfill Holdings, Inc.MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (“NextNRG” and the “Company”) (Nasdaq: NXXT), a company focused on renewable energy, mobile fueling, and next-generation energy infrastructure, today announced the closing of a public offering of 5,000,000 shares of common stock at a price to the public of $3.00 per share, for gross proceeds of $15,000,000, before deducting underwriting d ...